Pharmstandard-UfaVITA JSC

Company Profile

Contact information: Address: 28, Khudayberdin? str., Ufa, Republic of Bashkortostan, 450077
Telephone /fax: office (347) 273-15-83;
24-7 support (347) 272-92-85;
Chief Engineer (347) 272-06-43;
Quality Director (347) 272-35-34;
Commercial Director (347) 272-74-64.
Staff: 1,763 employees
Product range: 105 items
Number of SKU: 172 items
2016 Output: 86.4 mln packs
Awards and Achievements: The Best Industrial Company of the Republic of Bashkortostan in 2009;
Laureate of “The Best Manufacturer in Ufa” City Competition in nomination of “The Leader of Industry 2011”;
Laureate of “The Best Manufacturer in Ufa” City Competition in nomination of “Dynamic Development and Excellent Financial Performance 2014”.
GMP-certified since 2010.

Resources and Capabilities

Capacity: over 200 mln packs
Total area: 42 thd. sqm.
Manufacturing area: 18,950 thd. sqm.
Number of production lines: 19
Manufacturing dosage forms: Solid
  • tablets, incl. film-coated
  • pills
  • capsules
Liquid and freeze-dried
  • injectables in ampoules, vials
  • cartridges, prefilled syringes
Infrastructure: Pharmstandard-UfaVITA JSC has all the necessary infrastructure in place to ensure high-quality product manufacturing:
• operating workshop premises;
• warehouses , required to store raw materials, materials and finished products;
• Quality Control laboratories, responsible for the quality control of purchased and finished products, intermediates.

Power sources and utilities:
• gasified boiler house;
• two independent power feeds;
• oxygen and nitrogen generators;
• compressed air generator;
• WFI and PW generation systems.


Director General

Vladimir Kreyman

1984 – Majored in Mechanical Engineering, Metal-Cutting Machines and Equipment by the Novosibirsk State Technical University. Obtained the qualification of mechanical engineer.
Before 1987 - Worked in the Pneumatic Machines Dynamics Laboratory at the Mining Institute of the Siberian Branch of the Soviet Union Academy of Sciences. Obtained 11 inventor’s certificates and patents.
Worked as Chief Designer at the Tomsk Vakhrushev Electromechanical Plant;
1996 - 1999 — Held the position of Executive Director and subsequently Commercial Director of ProfitMed CJSC.
1999 - Took office of Finished Product Sales Director at Ufimsky Vitamin Plant OJSC. The same year, pursuant to the Resolution of the Board of Directors, appointed as Director General.

History and Milestones

In 1916, a confectionery plant was opened in Ufa, in 1941 to be converted into a vitamin plant based on the production facilities transferred to the Ural region.
The plant was the first to manufacture the pharmaceuticals that would subsequently become acknowledged nationwide: Pangamate (vitamin ?15), Decamevit®, Aerovit®, Complivit®, Selmevit®, and a wide range of other high-performance pharmaceuticals and coenzymes in freeze-dried forms for injections.
Joined Pharmstandard Group. In 2004 it was renamed into Pharmstandard-UfaVITA JSC.
Put in commission:
• Workshop No.4 for injectables — manufacturing of injactables in ampoules with terminal sterilisation;
• Workshop No.4 for insulin products – aseptic manufacturing of products in vials and cartridges;
• Workshop No.1 for multivitamins — manufacturing of film-coated tablets;
• Workshop No.4 for lyophilized products — manufacturing of lyophilisates for injection solutions;
• Workshop No.5 for injectables — expanded manufacturing area for injectables in ampoules.
Put in commission liquid dosage form packaging area (Workshop No.5).
Launched contract manufacturing of F.Hoffman—La Roche cold-chain products.
Expanded manufacturing of injectables in ampoules: put in commission another injectable area (Workshop No.5 ).
Put in commission Workshop No.2 for manufacturing of cytostatics, including the manufacturing area for injactables in liquid and freeze-dried forms, manufacturing area for tablets and capsules, packaging area.
Arranged manufacturing processes within the facilities equipped with isolators.
Expanded injectable manufacturing: put in commission the manufacturing area for injactables in pre-filled syringes (Workshop No.4).
Obtained Certificate of GMP Compliance Manufacturer, in accordance with Directive 2003/94/EC, issued by State Agency of Medicines of the Republic of Latvia: ZVA/LV/2015/004H (dd.30.04.2015).
Obtained Resolution on GMP Compliance of the manufacturer of pharmaceutical products for medical use, issued by the Ministry of Industry and Trade of the Russian Federation: No.GMP -0002-000125/16 (dd.10.10.2016).
Obtained Certificate of Compliance with GOST R ISO 9001-2015 No.ROSS RU.IM00.I0035 (dd. 22.05.2016).
Obtained Drug Manufacturing License No.00071-LS (dd.20.01.2017).

Development Plans

2017 To expand the range of the manufactured products:
• to develop 7 original formulations;
• to localise (technology transfer) 51 items, including:
-full cycle — 38 items;
-secondary packaging — 13 items;
• to reformulate, repackage — 83 items;
To reconstruct the facilities of the insulin product manufacturing area, to reconstruct the injectable manufacturing area No.1, arranging small-batch manufacturing.
2018 To expand the range of the manufactured products:
• to develop 6 original formulations;
• to localise (technology transfer) 86 items;
• to reformulate, repackage — 74 items;
To expand the manufacturing facilities.


5B, Likhachyovsky Proezd, Dolgoprudny, Moscow Region, 141701, Russia

+7 (495) 970 0030/32


© 2007–2017

All rights reserved. JSC Pharmstandard.
Terms of use Disclosure of information.


Информация на сайте предназначена исключительно для медицинских работников.

Подтвердите, пожалуйста, являетесь ли Вы медицинским работником.

Если Вы не являетесь медицинским работником, пожалуйста, покиньте данный раздел сайта.


1.На сайте представлена информация о рецептурных препаратах, их свойствах, способах применения и возможных противопоказаниях исключительно специалистам здравоохранения (лицам, имеющим высшее или среднее специальное медицинское образование).

2. Если Вы являетесь специалистом здравоохранения и хотите получить информацию с данного раздела сайта, Вам необходимо подтвердить ваш статус специалиста здравоохранения.

3. В случае если Вы не являетесь специалистом здравоохранения, но в нарушение настоящих условий подписываете данное соглашение, сайт Компании не несет ответственности за возможные отрицательные последствия, возникшие в результате самостоятельного использования Вами информации с сайта, без предварительной консультации со специалистом. Вы делаете это самостоятельно и осознанно, понимая, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом здравоохранения.

4. Информация о рецептурных препаратах, представленная на данном разделе сайте, предназначена исключительно для ознакомления с препаратами и не является руководством для самостоятельной диагностики или лечения, и не служит в качестве медицинских советов или рекомендаций. Сайт не несет ответственности за возможный ущерб, нанесенный Вашему здоровью в случае самовольного лечения, проводимого на основании применения рецептурных препаратов (без предварительной консультации со специалистом). Настоящим я подтверждаю, что являюсь специалистом здравоохранения и подтверждаю своё согласие с тем, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом.